+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biomimetic Nanoengineered Materials for Advanced Drug Delivery

  • Book

  • November 2019
  • Elsevier Science and Technology
  • ID: 4753557

Biomimetic Nanoengineered Materials for Advanced Drug Delivery is an indispensable guide for new developments in biomimetic nanoengineering for advanced drug delivery applications. Focusing on the fundamentals of a new type of nanocarriers for drug delivery in the most recent miRNA therapeutics, the book provides readers with detailed knowledge from the basics, to the most recent innovations. Early chapters of the book discuss a range of drug delivery techniques, including nanofibers, biomimetic polymers, 3D bioprinting, nanotechnology and radiofrequency sensitive nanocarriers. Later chapters explore miRNA therapeutics, magnetic nanoparticles, nanogel-based and ROS-mediated drug delivery systems.

The book is a vital reference for biomaterials and nanomedicine researchers and clinicians with an interest in advanced drug delivery.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Introduction to smart drug delivery 2. Nanofibers based anticancer drug delivery platform 3. Biomimetic polymers for drug delivery and tissue engineering applications 4. Nanohybrid scaffold structures for smart drug delivery applications 5. 3D bioprinting for active drug delivery 6. Nano technology in Improving Medical Devices for smart drug delivery 7. Radiofrequency sensitive nanocarriers for cancer drug delivery 8. Targeting peptide modified polymeric nanoparticles for cardiac and pulmonary drug delivery applications 9. miRNA therapeutics: Applications of nanoparticle-based gene delivery 10. Magnetic nanoparticles for targeted drug delivery and gene therapy 11. Nanogel based active drug delivery 12. ROS mediated drug delivery systems for anticancer therapy 13. Drug Eluting Stents: present and future perspectives 14. Remotely controlled drug delivery systems 15. Nanoparticle-Plasma proteins interactions: pitfalls and opportunities on cancer drug delivery

Authors

Afeesh Rajan Unnithan Department of Bionanosystem, Engineering, Graduate School, Chonbuk National University. Afeesh Rajan Unnithan is currently working as the KRF (Korean Research Fellow) at Chonbuk National University, South Korea. Dr. Afeesh also worked as the Assistant Research Professor at Chonbuk National University from 2013 to 2016. He completed Ph.D. in Bionanosystem Engineering from Chonbuk National University in 2013. Dr. Afeesh obtained his M.Tech in Nanomedicine from Amrita Centre for Nanosciences and Molecular Medicine and B.Tech in Biotechnology from Anna University, India. Dr. Afeesh's principal research interests are in the areas related to the preparation of Nanobiomaterials, Smart Drug Delivery systems, Hyperthermic Chemotherapy, Bioactive Nanostructured-Scaffolds, Electrospinning, 3D Bioprinting etc. He published around 40 peer reviewed research articles in high impact factor journals with 563 citations. Arathyram Ramachandra Kurup Sasikala Department of Bionanosystem, Engineering, Graduate School, Chonbuk National University. Arathyram Ramachandra Kurup Sasikala is currently working as an Assistant Research Professor at Chonbuk National University, South Korea. She obtained her Ph.D. in Bionanosystem Engineering from Chonbuk National University in August 2016. Dr. Arathy completed her MSc and BSc in Physics from University of Kerala, India. Dr. Arathy also worked as a Junior Research Fellow in National Remote Sensing Centre, ISRO (Indian Space Research Organization), India. Her principal research interest lies in the development of multifunctional therapeutic nanosystems incorporating both magnetic nanomaterials and drugs for the synergistic cancer theranostics by combining hyperthermia, chemotherapy and MRI. Dr. Arathy published her research works in high impact journals such as Advanced Functional Materials, Nanoscale, Acta Biomaterialia, Scientific Reports, Journal of Materials Chemistry B, ACS applied materials & interfaces, Chemical Engineering Journal etc. Chan Hee Park Department of Bionanosystem, Engineering, Graduate School, Chonbuk National University. Chan Hee Park is currently working as an Associate Professor in Department of Bionanosystem Engineering at Chonbuk National University, South Korea. He obtained his Ph.D. in Bionanosystem Engineering from Chonbuk National University in 2012. He worked for National Instruments (USA) from 2002 to 2009. Following that he worked as the Team Leader Senior Researcher at R&D Division, Chonbuk National University Automobile Parts & mold Technology Innovation Center, Jeonju. Prof. Park's research interests are related to Electrospun Nano composite materials for drug delivery, Microfluidics/Electroanalytical Biosensors, Biodegradable Metals, Regenerative Medicine, Nanomedicine etc. He published his research achievements in various peer reviewed journals with 2124 citations. Cheol Sang Kim Department of Bionanosystem, Engineering, Graduate School, Chonbuk National University. Cheol-Sang Kim received his B.S. and M.S. degrees in Mechanical Engineering from Chonbuk National University in Korea in 1980 and 1982, respectively. He then received the Ph.D. degree in Material Science at Universite de Louis Pasteur in Strasbourg, France in 1988. Dr. Kim is currently Professor at the Division of Mechanical Engineering and Dean of College of Engineering at Chonbuk National University in Korea. Prior to joining Chonbuk National University, he spent two years at the Department of Bioengineering at University of Pennsylvania (U.S.A) as a Post Doc. fellow. He worked for five years from 1997 as a Head of Institute of Biomedical Engineering, Solco Surgical Instruments Co., Ltd. and Institute of Interventional Medicine, M.I.Tech Co., Ltd., Korea.
Dr. Kim's research interests are in the area of biomaterials for hard tissue replacements, Drug delivery, design and analysis of implants and artificial organs, and anti-biofouling technology. Dr. Kim owns numerous publications in high impact factor journals with 2426 Citations.